<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04501731</url>
  </required_header>
  <id_info>
    <org_study_id>20047</org_study_id>
    <nct_id>NCT04501731</nct_id>
  </id_info>
  <brief_title>Controlling Coordination After Childhood Cerebellar Cancer, a Pilot Study</brief_title>
  <acronym>5C-pilot</acronym>
  <official_title>Controlling Coordination After Childhood Cerebellar Cancer - Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nottingham University Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nottingham Hospitals Charity</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Posterior fossa tumours (PFT) account for 2/3 of childhood brain cancers. They can be highly&#xD;
      malignant requiring combined chemotherapy and radiotherapy post-surgery for a &gt;50% chance of&#xD;
      cure. PFT frequently involve the cerebellum which is responsible for coordinating movement,&#xD;
      balance, emotional control, and links closely to control of affect and executive function.&#xD;
      PFT survivors show highly variable profiles for cognitive and sensorimotor functioning which&#xD;
      are influenced strongly by the severity of the pre-diagnostic or post-surgical brain injury&#xD;
&#xD;
      State-of-the-art magnetic resonance imaging (MRI) scans can allow to measure a variety of&#xD;
      different biological processes in the brain, and the investigators believe that some of these&#xD;
      MRI measures (called MRI biomarkers) have the potential to improve our ability to understand&#xD;
      and monitor consequences of the ablative brain surgery and complex mechanisms of motor skills&#xD;
      recovery. Biomarkers are very important for the development of intervention because 1) they&#xD;
      help understand the recuperation process and 2) they allow to effectively assess whether or&#xD;
      not a treatment or intervention works.&#xD;
&#xD;
      Transcranial magnetic stimulation (TMS) is a powerful non-invasive neuro-modulatory&#xD;
      intervention that has the potential to evaluate the integrity of the nervous tracts from the&#xD;
      brain to the hand. It is a procedure that applies magnetic pulses on the surface of the scalp&#xD;
      to reach underlying brain tissue. TMS has built a reputable status among neuro-rehabilitative&#xD;
      research, and there is currently a major effort to translate the positive research findings&#xD;
      into clinically useful therapeutic strategies.&#xD;
&#xD;
      This study is therefore an important first step towards understanding how potential MRI&#xD;
      biomarkers and responses to TMS relate to motor symptoms in PFT young survivors. Once&#xD;
      completed, this study will allow the investigators to select the most promising MRI&#xD;
      biomarkers and TMS protocols to take forward into future treatment trials. The investigators&#xD;
      aim to stimulate the recovery of coordination skills, help the development of targeted&#xD;
      therapies, and consequently improve long-term quality of life in children and young people&#xD;
      with history of brain tumour.&#xD;
&#xD;
      The proposed research intends to prove the feasibility of such brain stimulation and imaging&#xD;
      and collect some preliminary measures&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>5C-pilot Satisfaction Questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>Participants rating their experience of MRI, TMS and motor assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Completion rate of the sessions of TMS, MRI and motor tasks</measure>
    <time_frame>6 months</time_frame>
    <description>Measure of quality of MRI images (participants motion) - Feasibility will be confirmed if 50% or more of these participants complete the TMS session</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anatomical MRI metrics (PFT vs control)</measure>
    <time_frame>1 year</time_frame>
    <description>Cerebellar volumetry and cerebellar parcellation - after surgery (mm3)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fMRI metrics (PFT vs control)</measure>
    <time_frame>1 year</time_frame>
    <description>Functional connectivity within sensorimotor network (activation map)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diffusion MRI metrics (PFT vs control)</measure>
    <time_frame>1 year</time_frame>
    <description>Anatomical connectivity within sensorimotor network (tractography)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Single-pulse TMS metrics (PFT vs control)</measure>
    <time_frame>1 year</time_frame>
    <description>Resting motor threshold (Stimulus intensity expressed as a percentage of maximal stimulator output)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Single-pulse TMS metrics (PFT vs control)</measure>
    <time_frame>1 year</time_frame>
    <description>input-output curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Single-pulse TMS metrics (PFT vs control)</measure>
    <time_frame>1 year</time_frame>
    <description>Silent period (ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Single-pulse TMS metrics (PFT vs control)</measure>
    <time_frame>1 year</time_frame>
    <description>Short-afferent inhibition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dual-pulse TMS metrics (PFT vs control)</measure>
    <time_frame>1 year</time_frame>
    <description>Intracortical &amp; long-latency inhibition and facilitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dual-pulse TMS metrics (PFT vs control)</measure>
    <time_frame>1 year</time_frame>
    <description>cerebellar-motor inhibition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor performance (PFT vs control) - Reaching and grasping task</measure>
    <time_frame>1 year</time_frame>
    <description>Kinematic parameters of movement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor performance (PFT vs control) - Grooved pegboard</measure>
    <time_frame>1 year</time_frame>
    <description>Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor performance (PFT vs control) - Grip force</measure>
    <time_frame>1 year</time_frame>
    <description>Maximum force (N)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life of PFT survivors: FACT-Peds-Br Questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>FACT-Peds-Br Pediatric Questionnaire - For patients with Brain cancer</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Brain Cancer</condition>
  <arm_group>
    <arm_group_label>Young PFT survivors</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Age-matching controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation (TMS)</intervention_name>
    <description>With the TMS session we gather information about nerve fibres from the brain to the hand. It will last around 2 hours and 30 minutes.</description>
    <arm_group_label>Age-matching controls</arm_group_label>
    <arm_group_label>Young PFT survivors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Magnetic Resonance Imaging (MRI)</intervention_name>
    <description>With the MRI scan we will gather information about the brain structure and function. This will last around 30 minutes.</description>
    <arm_group_label>Age-matching controls</arm_group_label>
    <arm_group_label>Young PFT survivors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Motor assessment</intervention_name>
    <description>The motor assessment includes a pegboard game, a &quot;grab the alien nose&quot; game and measure of your maximum grip force. In total it will last around 30 minutes.</description>
    <arm_group_label>Age-matching controls</arm_group_label>
    <arm_group_label>Young PFT survivors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Feasibility, tolerability of such intervention as well as quality of life of PFT survivors will be assessed thanks to questionnaires.</description>
    <arm_group_label>Young PFT survivors</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        4 participants with history of PFT (no history of seizure, no current cancer treatment) 6&#xD;
        healthy controls (no history of brain injury)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to undergo MRI scan without sedation or general anaesthetic&#xD;
&#xD;
          -  Able to give informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of seizure&#xD;
&#xD;
          -  Current cancer or post surgery treatment&#xD;
&#xD;
          -  Contraindication to TMS or MRI&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>22 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 23, 2020</study_first_submitted>
  <study_first_submitted_qc>August 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2020</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Motor recovery</keyword>
  <keyword>Transcranial Magnetic Stimulation</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Paediatric</keyword>
  <keyword>Cerebellum</keyword>
  <keyword>Posterior Fossa Tumour</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
    <mesh_term>Cerebellar Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

